Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

Acta neuropathologica - 1 Apr 2008

Jellinger Kurt A, Attems Johannes

Abstract excerpt

Whereas the prevalence and impact of vascular pathology in Alzheimer diease (AD) are well established, the role of vascular and Alzheimer pathologies in the progression of neurodegeneration and cognitive impairment in Parkinson disease (PD) is under discussion. A retrospective clinico-pathologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lewy Body Disease

Share to Prevalence

Share to Psychiatric Status Rating Scales

Share to Severity of Illness Index

Share to Vascular Diseases

Source

Identifiers

PMID: 18273624
DOI: 10.1007/s00401-008-0347-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18273624-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.PMID 18273624Read ↗

Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic MechanismsSemantic proximity Read ↗

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy BodiesSemantic proximity Read ↗

Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?Semantic proximity Read ↗

Dementia with Lewy bodies.Semantic proximity Read ↗

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?Semantic proximity Read ↗

Dementia with Lewy bodies.Semantic proximity Read ↗

Cognitive impairment in Parkinson's disease : impact and identification of comorbid disease mechanismsSemantic proximity Read ↗

Multiple substrates of late-onset dementia: implications for brain protection.Semantic proximity Read ↗

β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.Semantic proximity Read ↗

Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and ManagementSemantic proximity Read ↗

Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.Semantic proximity Read ↗

Senile plaques in Alzheimer’s disease arise from Aβ and Cathepsin D-enriched amyloidogenic mixtures out of intravascular hemolysis and Charcot-Bouchard aneurysm-related vascular degenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.